That is the conclusion of draft guidance which says that the evidence for Lynparza (olaparib) as a treatment for prostate cancer is uncertain, and therefore not a good use of NHS funds.

Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines under the ...

and compared Lynparza (olaparib) to placebo as a post-surgery regimen to try to prevent the cancer from coming back. The new analysis – presented at the San Antonio Breast Cancer Symposium ...

The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...

The company said it concluded the Phase 1b dose escalation study of NUV-868 in combination with AstraZeneca Plc (NASDAQ:AZN)-Merck & Co Inc’s (NYSE:MRK) Lynparza (olaparib) for ovarian ...

AstraZeneca Pharma India (APIL) was incorporated on July 11 1979. The Company is engaged in the business of manufacture distribution and marketing of pharmaceutical products and co-ordinates clinical ...

In 2023, the global breast cancer drug market is projected to be worth USD 10,733.1 million.  Between 2023 and 2033, the demand for breast cancer drugs is expected to expand at a CAGR of 1.1%, ...

A New York appellate court on Tuesday denied President-elect Donald Trump's bid to halt sentencing set for Friday for his conviction on criminal charges stemming from hush money paid to a porn ...

A force fighting Sudan’s army in a brutal civil war committed massacres and rape that amount to genocide, the Secretary of State said, two decades after a finding of genocide in the same region ...

An Emboldened Trump Talks of Taking Greenland and Panama Canal by Force In a rambling news conference from his private Florida club, President-elect Trump refused to rule out using military force ...